Statin Use is Associated with a Lower Risk of Multiple Myeloma:A Systematic Review and Meta-analysis

Data on statin use and risk of multiple myeloma is still conflicting. We performed a systematic review that comprised of terms for “statin” and “multiple myeloma” and identified 10 eligible studies for meta-analysis. The risk of multiple myeloma was significantly lower among statin-users than non-users with the pooled odds ratio of 0.80 (95% CI, 0.68 – 0.93; I2 = 72%).

Source: Clinical Lymphoma, Myeloma and Leukemia - February 25, 2020 Category: Hematology Authors: Ben Ponvilawan, Nipith Charoenngam, Thanitsara Rittiphairoj, Patompong Ungprasert Tags: Original Study Source Type: research